Bone mineral density and turnover in children with attention-deficit hyperactivity disorder receiving methylphenidate

Journal of Child Neurology

Volumn 15, Issue 7, 2000, Pages 436-439

  Lahat, Eliezer ^a,b   Weiss, Mordechai ^a,b   Ben Shlomo, Anat ^a,b   Evans, Sandra ^a,b   Bistritzer, Tzvy ^a,b  

^a ASSAF HAROFEH MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; DEOXYPYRIDINOLINE; METHYLPHENIDATE;

ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ATTENTION DEFICIT DISORDER; BONE DENSITY; BONE MINERALIZATION; BONE TURNOVER; CHILD; CHILD GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMUR NECK; HUMAN; LUMBAR SPINE; MALE; PHOTON ABSORPTIOMETRY; PRIORITY JOURNAL; URINARY EXCRETION;

EID: 0033941822     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/088307380001500702     Document Type: Article

References (26)

1. Baumgaertel A, Wolraich ML: Practice guideline for the diagnosis and management of attention deficit hyperactivity disorder. Ambulatory Child Health 1998;4:45-58.
2. Hill P: Attention deficit hyperactivity disorder. Arch Dis Child 1998; 79:381-385.
3. Ala-Houhala M, Korpela R, Koivikko M, et al: Long term anticonvulsant therapy and vitamin D mechanism in ambulatory pubertal children. Neuropediatrics 1986;17:212-216.
4. Akin R, Ukuten V, Sarici U, et al: Evaluation of bone mineral density in children receiving antiepileptic drugs. Pediatr Neurol 1998; 19:129-131.
5. Henderson R: Bone density and other possible predictors of fracture risk in children and adolescents with spastic quadriplegia. Dev Med Child Neurol 1997;39:224-227.
6. Price CP: Multiple forms of human serum alkaline phosphatase: Detection and quantitation. Ann Clin Biochem 1993;30:355-372.
7. Price CP, Thompson PW: The role of biochemical tests in the screening and monitoring of osteoporosis. Ann Clin Biochem 1995;32:244-260.
8. Seyedin SM, Rosen DM: Matrix protein of the skeleton. Curr Opin Cell Biol 1990;2:914-919.
9. Delmas PD, Gineyts E, Bertholin A, et al: Immunoassay of pyridinoline crosslink excretion in normal adults and in Paget's disease. J Bone Miner Res 1993;8:643-648.
10. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, American Psychiatric Association, 1994.
11. Delmas PD: Biochemical markers of bone turnover. J Bone Miner Res 1993;8(Suppl):S549-S555.
12. Robins SP, Stewart P, Astbury C, Bird HA: Measurement of the cross-linking compound, pyridinoline in urine as an index of collagen degradation. Ann Rheum Dis 1986;45:969-973.
13. Demers LM, Kleerekoper M: Recent advances in biochemical markers of bone turnover, editorial. Clin Chem 1994;40:1994-1995.
14. Stevenson RD, Wolraich ML: Stimulant medication therapy in the treatment of children with attention deficit hyperactivity disorder. Pediatr Clin North Am 1989;36:1183-1198.
15. Safer D, Allen R, Barr F: Depression of growth in hyperactive children on stimulant drugs. N Engl J Med 1972;287:217.
16. Roche AF, Lipman RS, Overall JE, Hung W: The effects of stimulant medications on the growth of hyperkinetic children. Pediatrics 1979;63:847-850.
17. Schultz FR, Hayford JT, Wolraich ML, et al: Methylphenidate treatment of hyperactive children: Effects on the hypothalamic-pituitary-somatomedin axis. Pediatrics 1982;70:987-992.
18. Kalachnik JF, Sprague RL, Sleator EK: Effect of methylphenidate hydrochloride on stature of hyperactive children. Dev Med Child Neurol 1982;24:586-595.
19. Mattes JA, Gittelman R: Growth of hyperactive children on maintenance regimen of methylphenidate. Arch Gen Psychiatry 1983; 40:317-321.
20. Committee on Children with Disabilities, Committee on Drugs: Medication for children with an attention deficit disorder. Pediatrics 1987;80:758.
21. Kilgore BS, Dickinson LC, Burnett CR, et al: Alternations in cartilage metabolism by neurostimulant drugs. J Pediatr 1973;94: 542-548.
22. Conard CJ, Charles WS, Joseph ML: Clinical use of bone densiometry. N Engl J Med 1991;324:1105-1109.
23. Lang P, Steiger P, Faulkner K, et al: Osteoporosis: Current techniques and recent developments in quantitative bone densiometry. Radiol Clin North Am 1991;29:49-76.
24. Tsukahara H, Suto M, Urrezak M: Measurement of lumbar spinal bone mineral density in preterm infants by dual-energy x-ray absorptiometry. Biol Neonate 1993;64:96-103.
25. Onse S, Mimaki T, Seino Y, et al: Delayed bone development in epileptic children assessed by microdensitometer. Dev Pharmacol Ther 1988;11:24-31.
26. Nishiyama S, Kuwakara T, Matsuda I: Decreased bone density in severely handicapped children and adults, with reference to the influence of limited morbidity and anticonvulsant medication. Eur J Pediatr 1988;144:457-463.